Status:

COMPLETED

Long Term Integrity Follow-up Evaluation

Lead Sponsor:

Guidant Corporation

Conditions:

Sudden Cardiac Death

Eligibility:

All Genders

18+ years

Brief Summary

To document the performance of the Guidant ENDOTAK EZ and the RELIANCE defibrillation leads over 5 years.

Detailed Description

There are few prospective long term follow-up studies on implanted cardiac device (pacemaker/implantable cardioverter defibrillator (ICD)) survivability. This study will evaluate the long term perform...

Eligibility Criteria

Inclusion

  • Patients selected for Guidant ICD system implant, available for follow-up at the defined intervals

Exclusion

  • Patients enrolled in other studies, not available for follow-up, \< 18 yrs, unable to sign consent, life expectancy \< 1 year due to a medical condition

Key Trial Info

Start Date :

March 1 2002

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

372 Patients enrolled

Trial Details

Trial ID

NCT00848835

Start Date

March 1 2002

End Date

January 1 2010

Last Update

August 31 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Long Term Integrity Follow-up Evaluation | DecenTrialz